These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 37710283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.
    Holmes EE, Jung M, Meller S, Leisse A, Sailer V, Zech J, Mengdehl M, Garbe LA, Uhl B, Kristiansen G, Dietrich D.
    PLoS One; 2014; 9(4):e93933. PubMed ID: 24699908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK, Kalmár A, Galamb O, Wichmann B, Nagy ZB, Tulassay Z, Dank M, Igaz P, Molnár B.
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [Abstract] [Full Text] [Related]

  • 8. Bisulfite-Converted DNA Quantity Evaluation: A Multiplex Quantitative Real-Time PCR System for Evaluation of Bisulfite Conversion.
    Hong SR, Shin KJ.
    Front Genet; 2021 Jul; 12():618955. PubMed ID: 33719336
    [Abstract] [Full Text] [Related]

  • 9. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
    Wang M, Huang X, Li X, Guo Q, Xu W, Zhao M, Wang X, Wang L, Lou J.
    Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
    Pérez-Barrios C, Nieto-Alcolado I, Torrente M, Jiménez-Sánchez C, Calvo V, Gutierrez-Sanz L, Palka M, Donoso-Navarro E, Provencio M, Romero A.
    Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
    [Abstract] [Full Text] [Related]

  • 12. A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinoma.
    Mohamed FR, Rose A, Sheehan-Hennessy L, Pedersen SK, Cornthwaite K, Laven-Law G, Young GP, Symonds EL, Winter JM.
    Cancer Treat Res Commun; 2024 Dec; 40():100838. PubMed ID: 39154541
    [Abstract] [Full Text] [Related]

  • 13. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
    Terp SK, Pedersen IS, Stoico MP.
    J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
    [Abstract] [Full Text] [Related]

  • 14. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA.
    Janku F, Huang HJ, Pereira DY, Kobayashi M, Chiu CH, Call SG, Woodbury KT, Chao F, Marshak DR, Chiu RYT.
    Sci Rep; 2021 Oct 04; 11(1):19653. PubMed ID: 34608196
    [Abstract] [Full Text] [Related]

  • 15. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J, Abramovic I, Vrtaric A, Nikolac Gabaj N, Kralik-Oguic S, Katusic Bojanac A, Jezek D, Sincic N.
    Front Cell Dev Biol; 2021 Oct 04; 9():686149. PubMed ID: 34552921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight.
    Werner B, Yuwono NL, Henry C, Gunther K, Rapkins RW, Ford CE, Warton K.
    PLoS One; 2019 Oct 04; 14(10):e0224338. PubMed ID: 31652288
    [Abstract] [Full Text] [Related]

  • 19. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
    van Ginkel JH, van den Broek DA, van Kuik J, Linders D, de Weger R, Willems SM, Huibers MMH.
    Cancer Med; 2017 Oct 04; 6(10):2297-2307. PubMed ID: 28940814
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.